Cyclooxygenase-2 inhibitor induces operational tolerance to fully allogenic cardiac grafts.
Yokoyama
T
T
Department of Surgery, Nihon University, 30-1 Ohyagutikamimati, Itabashi-ku, Tokyo, Japan 173-8610.
Aramaki
O
O
Takano
S
S
Takayama
T
T
Akiyama
Y
Y
Shibutani
S
S
Shirasugi
N
N
Kan
S
S
Ikeda
Y
Y
Niimi
M
M
D000818:Animals; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology*; D006085:Graft Survival / Q000187:drug effects*; D016027:Heart Transplantation / Q000276:immunology*; D007108:Immune Tolerance / Q000187:drug effects*; D007527:Isoenzymes / Q000378:metabolism; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D009578:Nitrobenzenes / Q000494:pharmacology*; D011451:Prostaglandin-Endoperoxide Synthases / Q000378:metabolism; D013449:Sulfonamides / Q000494:pharmacology*; D014184:Transplantation, Homologous
D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D009578:Nitrobenzenes; D013449:Sulfonamides; C080955:N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide; D051546:Cyclooxygenase 2; D011451:Prostaglandin-Endoperoxide Synthases